Sarepta Therapeutics, Inc.
SRPT
$18.84
-$0.29-1.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.95% | -30.64% | -28.99% | -45.21% | -62.41% |
| Total Receivables | -24.38% | -20.27% | 4.96% | 55.41% | 72.76% |
| Inventory | 6.34% | 21.97% | 90.34% | 104.62% | 152.04% |
| Prepaid Expenses | -2.36% | -11.07% | -5.36% | 0.05% | -14.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -63.15% | -52.60% | -40.38% | -29.57% | -13.12% |
| Total Current Assets | -5.04% | -17.42% | 1.38% | -0.99% | -1.31% |
|
|
|||||
| Total Current Assets | -5.04% | -17.42% | 1.38% | -0.99% | -1.31% |
| Net Property, Plant & Equipment | -9.33% | -3.69% | 11.51% | 28.66% | 35.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 19.79% | 7.67% | 7.67% | 8.03% | -9.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.75% | 27.11% | -7.75% | 43.05% | 23.52% |
| Total Assets | -8.27% | -15.48% | -2.96% | 7.46% | 7.47% |
|
|
|||||
| Total Accounts Payable | -54.92% | 30.96% | -20.85% | 27.26% | 70.54% |
| Total Accrued Expenses | -2.50% | -3.88% | -27.20% | -0.56% | 14.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.00% | -- | -90.66% | -90.41% | -89.35% |
| Total Finance Division Other Current Liabilities | -5.29% | 109.37% | 158.41% | 113.35% | 7.80% |
| Total Other Current Liabilities | -5.29% | 109.37% | 158.41% | 113.35% | 7.80% |
| Total Current Liabilities | -17.57% | 49.69% | 31.73% | 33.62% | -0.51% |
|
|
|||||
| Total Current Liabilities | -17.57% | 49.69% | 31.73% | 33.62% | -0.51% |
| Long-Term Debt | -26.37% | -27.10% | -8.88% | 0.41% | 0.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.39% | 3.59% | 26.49% | 49.32% | 46.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -63.03% | -77.16% | -99.54% | -87.22% | -1.94% |
| Total Liabilities | -27.93% | -9.29% | -8.64% | -1.05% | 2.63% |
|
|
|||||
| Common Stock & APIC | 4.75% | 5.29% | 7.12% | 6.61% | 7.99% |
| Retained Earnings | 2.41% | -15.82% | -6.21% | -1.32% | -5.63% |
| Treasury Stock & Other | -74,758.82% | -11,363.76% | -1,215.50% | -2,357.67% | 104.92% |
| Total Common Equity | 31.71% | -25.34% | 8.11% | 26.03% | 18.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.71% | -25.34% | 8.11% | 26.03% | 18.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.71% | -25.34% | 8.11% | 26.03% | 18.89% |
|
|
|||||